Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over.
Alicandro G, Daccó V, Cariani L, Contarini M, Morlacchi LC, Rosazza C, Sciarrabba CS, Ferraro F, Lanfranchi C, Orena BS, Gramegna A, Blasi F, Colombo C.
Alicandro G, et al. Among authors: sciarrabba cs.
J Cyst Fibros. 2022 May;21(3):e173-e175. doi: 10.1016/j.jcf.2022.02.009. Epub 2022 Feb 16.
J Cyst Fibros. 2022.
PMID: 35256306
Free PMC article.
No abstract available.